NSD3-NUT fusion oncoprotein in NUT midline carcinoma: Implications for a novel oncogenic mechanism Journal Article


Authors: French, C. A.; Rahman, S.; Walsh, E. M.; Kühnle, S.; Grayson, A. R.; Lemieux, M. E.; Grunfeld, N.; Rubin, B. P.; Antonescu, C. R.; Zhang, S.; Venkatramani, R.; Dal Cin, P.; Howley, P. M.
Article Title: NSD3-NUT fusion oncoprotein in NUT midline carcinoma: Implications for a novel oncogenic mechanism
Abstract: NUT midline carcinoma (NMC) is an aggressive subtype of squamous cell carcinoma that typically harbors BRD4/3-NUT fusion oncoproteins that block differentiation and maintain tumor growth. In 20% of cases, NUT is fused to uncharacterized non-BRD gene(s). We established a new patient-derived NMC cell line (1221) and demonstrated that it harbors a novel NSD3-NUT fusion oncogene. We find that NSD3-NUT is both necessary and sufficient for the blockade of differentiation and maintenance of proliferation in NMC cells. NSD3-NUT binds to BRD4, and BRD bromodomain inhibitors induce differentiation and arrest proliferation of 1221 cells. We find further that NSD3 is required for the blockade of differentiation in BRD4-NUT-expressing NMCs. These findings identify NSD3 as a novel critical oncogenic component and potential therapeutic target in NMC. SIGNIFICANCE: The existence of a family of fusion oncogenes in squamous cell carcinoma is unprecedented, and should lead to key insights into aberrant differentiation in NMC and possibly other squamous cell carcinomas. The involvement of the NSD3 methyltransferase as a component of the NUT fusion protein oncogenic complex identifies a new potential therapeutic target. © 2014 American Association for Cancer Research.
Keywords: immunohistochemistry; controlled study; unclassified drug; oncoprotein; human cell; squamous cell carcinoma; ki 67 antigen; cell proliferation; reverse transcription polymerase chain reaction; gene expression; small interfering rna; cell differentiation; fluorescence in situ hybridization; hybrid protein; cell culture; western blotting; immunoprecipitation; plasmid; gene silencing; immunofluorescence test; rna sequence; nonviral gene delivery system; nut midline carcinoma; human; article; cell viability assay; involucrin; nsd3 oncoprotein; nut oncoprotein
Journal Title: Cancer Discovery
Volume: 4
Issue: 8
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2014-08-01
Start Page: 929
End Page: 941
Language: English
DOI: 10.1158/2159-8290.cd-14-0014
PROVIDER: scopus
PMCID: PMC4125436
PUBMED: 24875858
DOI/URL:
Notes: Export Date: 2 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Cristina R Antonescu
    895 Antonescu